Total Payments
$144,389
2024 Payments
$7,661
Companies
13
Transactions
168
Medicare Patients
860
Medicare Billing
$208,825
Payment Breakdown by Category
Other$106,960 (74.1%)
Travel$19,442 (13.5%)
Consulting$13,064 (9.0%)
Food & Beverage$4,731 (3.3%)
Research$150.00 (0.1%)
Education$42.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $55,830 | 32 | 38.7% |
| Honoraria | $51,130 | 25 | 35.4% |
| Travel and Lodging | $19,442 | 45 | 13.5% |
| Consulting Fee | $13,064 | 10 | 9.0% |
| Food and Beverage | $4,731 | 54 | 3.3% |
| Unspecified | $150.00 | 1 | 0.1% |
| Education | $42.00 | 1 | 0.0% |
Payments by Type
General
$144,239
167 transactions
Research
$150.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, LLC | $48,979 | 72 | $0 (2020) |
| C. R. Bard, Inc. & Subsidiaries | $37,660 | 37 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $21,807 | 20 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $17,999 | 19 | $0 (2024) |
| MEDIVANCE, INC. | $13,328 | 10 | $0 (2019) |
| Ceribell, Inc. | $3,940 | 1 | $0 (2024) |
| Stryker Corporation | $250.00 | 1 | $0 (2018) |
| ZOLL Circulation Inc | $140.00 | 1 | $0 (2017) |
| Amgen Inc. | $123.09 | 1 | $0 (2017) |
| Philips North America LLC | $50.56 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,661 | 8 | Ceribell, Inc. ($3,940) |
| 2023 | $11,111 | 9 | AstraZeneca Pharmaceuticals LP ($11,111) |
| 2022 | $4,990 | 8 | AstraZeneca Pharmaceuticals LP ($3,218) |
| 2021 | $20,057 | 19 | Alexion Pharmaceuticals, Inc. ($20,057) |
| 2020 | $7,560 | 10 | PORTOLA PHARMACEUTICALS, LLC ($5,653) |
| 2019 | $33,349 | 40 | PORTOLA PHARMACEUTICALS, INC. ($19,977) |
| 2018 | $59,398 | 72 | C. R. Bard, Inc. & Subsidiaries ($28,487) |
| 2017 | $263.09 | 2 | ZOLL Circulation Inc ($140.00) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Medical Device | ||||||
| 07/18/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $17.19 | General |
| Category: Medical Device | ||||||
| 06/01/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: Medical Device | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Rare Disease | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Rare Disease | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $45.09 | General |
| Category: Rare Disease | ||||||
| 03/01/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Consulting Fee | Cash or cash equivalent | $3,940.00 | General |
| Category: Neurology | ||||||
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Rare Disease | ||||||
| 11/16/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Rare Disease | ||||||
| 08/17/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Rare Disease | ||||||
| 08/09/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Rare Disease | ||||||
| 06/22/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Rare Disease | ||||||
| 06/20/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.09 | General |
| Category: Rare Disease | ||||||
| 06/13/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Rare Disease | ||||||
| 01/23/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $61.90 | General |
| Category: Rare Disease | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Rare Disease | ||||||
| 11/30/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $99.40 | General |
| Category: Rare Disease | ||||||
| 11/30/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $96.25 | General |
| Category: Rare Disease | ||||||
| 09/28/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Rare Disease | ||||||
| 09/21/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $122.71 | General |
| Category: Rare Disease | ||||||
| 08/11/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $21.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Rare Disease | ||||||
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Rare Disease | ||||||
| 02/20/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Rare Disease | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| INTREPID BMD1111 | C. R. BARD, INC. & SUBSIDIARIES | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 137 | 303 | $166,562 | $38,179 |
| 2022 | 3 | 193 | 396 | $249,612 | $58,742 |
| 2021 | 4 | 213 | 439 | $246,618 | $60,455 |
| 2020 | 8 | 317 | 475 | $175,566 | $51,449 |
Total Patients
860
Total Services
1,613
Medicare Billing
$208,825
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 65 | 163 | $136,105 | $29,410 | 21.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 119 | $27,727 | $7,948 | 28.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 21 | $2,730 | $820.00 | 30.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 94 | 249 | $207,915 | $47,709 | 22.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 47 | 73 | $24,455 | $6,490 | 26.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 74 | $17,242 | $4,543 | 26.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 82 | 218 | $182,030 | $42,970 | 23.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 64 | 128 | $42,880 | $11,641 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 54 | 80 | $18,640 | $5,012 | 26.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 13 | 13 | $3,068 | $831.71 | 27.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 83 | 135 | $90,606 | $26,222 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 102 | 170 | $39,301 | $10,919 | 27.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 48 | $15,790 | $4,432 | 28.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 27 | 27 | $12,340 | $4,319 | 35.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 14 | $5,890 | $1,679 | 28.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 30 | 49 | $4,032 | $1,663 | 41.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 21 | 21 | $4,850 | $1,300 | 26.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 11 | 11 | $2,757 | $915.13 | 33.2% |
About Dr. Fred Rincon, M.D
Dr. Fred Rincon, M.D is a Critical Care Medicine healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326159443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fred Rincon, M.D has received a total of $144,389 in payments from pharmaceutical and medical device companies, with $7,661 received in 2024. These payments were reported across 168 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($55,830).
As a Medicare-enrolled provider, Rincon has provided services to 860 Medicare beneficiaries, totaling 1,613 services with total Medicare billing of $208,825. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Neurology, Vascular Neurology
- Location Camden, NJ
- Active Since 08/31/2006
- Last Updated 08/31/2020
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1326159443
Products in Payments
- ANDEXXA (Biological) $45,223
- ARCTIC SUN (Device) $28,974
- Andexxa (Drug) $20,057
- BEVYXXA (Drug) $19,615
- POCKET EEG DEVICE (Device) $3,940
- ANDEXXA (Drug) $3,735
- TREVO (Device) $250.00
- Temperature Management System (Device) $140.00
- Repatha (Biological) $123.09
- (5044) MCOT (Device) $50.56
- Briviact (Drug) $42.00
- CLEVIPREX (Drug) $21.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Camden
Dr. R. Phillip Dellinger, Md, MD
Critical Care Medicine — Payments: $78,129
Critical Care Medicine $78,129
Shawana Hussain, M.d, M.D
Critical Care Medicine — Payments: $19,418
Critical Care Medicine $19,418
Dr. Nagendra Madisi, Md, MD
Critical Care Medicine — Payments: $6,395
Critical Care Medicine $6,395
Fatima Wong
Critical Care Medicine — Payments: $6,320
Critical Care Medicine $6,320
Dr. Samson Zarbiv, M.d, M.D
Critical Care Medicine — Payments: $4,072
Critical Care Medicine $4,072
Dr. Nathalie Van Der Rijst, Md, MD
Critical Care Medicine — Payments: $3,367
Critical Care Medicine $3,367